Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.22%, DAX +0.15%, CAC40 +0.35%

Jan 09 ,2026

  • Synopsis

    • European indices are set to open slightly higher with Asian equities trading mostly higher. Strength led by Japan, mainland China and South Korea, all on track for sharp weekly gains.

    • US equities finished mostly higher in Thursday trading. Breadth was notably positive with equal-weight S&P outperforming the benchmark by more than 110 bp

    • Markets continue to monitor Venezuela developments and potential repercussions to other regions (Greenland, Ukraine/Russia and Japan/China in the mix as well).

    • In central banks, SNB preliminary 2025 results at 7:15CET and Czech central bank releases minutes of last MPC meeting. Denmark central bank releases its latest lending survey at 8:00CET. Denmark's Economic Society holds its annual meeting (through Sat), speakers include ECB's Lane 13:45CET and Denmark central bank Krogstrup speech at 12:00, panellist at 14:00. Chancellor Merz will attend the New Year's reception hosted by Federal President Frank-Walter Steinmeier. Syria's President al-Sharaa hosts EU's von der Leyen and Costa, the two EU leaders visiting Lebanon layer in the day. EU member states reportedly due to vote on EU-Mercosur trade deal

    • Macroeconomic releases due today include: Germany Nov trade balance, France Nov consumer goods spending, industrial production, Italy Nov retail sales, Eurozone Nov retail sales, Switzerland Dec unemployment rate, consumer confidence - SECO, Norway Dec CPI, PPI, Sweden Nov industrial production, Denmark Nov industrial production, Finland Nov industrial production, Netherlands Nov manufacturing production, Austria Nov industrial production, Greece Nov trade balance, industrial production

    • In early morning corporate news:

      • (CLAS.B.SS) Clas Ohlson reports Dec sales +5% to SEK1,676M; +7% organic. (TMV.GR) TeamViewer reports preliminary FY revenue €767M vs FactSet €764.3M. (TECN.SW) Tecan reports preliminary FY revenue CHF882.5M vs FactSet CHF886.7M.

    • Trading Update:

      • Nordics: Matas (MATAS.DC), Kid (KID.NO)

      • UK: J Sainsbury (SBRY.LN), UNITE Group (UTG.LN)

  • Politics/Macro/World News

    • UK to exclude financial services from push for closer EU alignment (FT )

    • Macron says France will vote against Mercosur after farmers protest in Paris (Reuters )

  • Top company news

    • Earnings/updates

      • YAR.NO (Yara International) -- to target over $600M in free cash flow expansion from 2024 to 2030 -- CMD

      • TECN.SW (Tecan Group) -- Tecan reports preliminary FY revenue CHF882.5M vs FactSet CHF886.7M [9 est, CHB868.4-894M]

      • ENX.FP (Euronext) -- Dec trading activity

      • TMV.GR (TeamViewer) -- reports preliminary FY revenue €767M vs FactSet €764.3M [15 est, €751-785M]

      • YPSN.SW (Ypsomed Holding) -- shares Q3 update in new quarterly CEO statement series

      • TGS.NO (TGS-NOPEC Geophysical Co.) -- operational update: expects multi-client investment to be ~$120M in Q4 2025 vs year-ago $100.4M

      • BCP.PL (Banco Comercial Portugues) -- informs about estimated provisions against legal risk related to FX mortgage loans portfolio booked by Bank Millennium, S.A. in 4Q 2025

      • FLOW.NA (Flow Traders) -- publishes the Q4 of 2025 pre-close call script

      • SIGHT.FP (GenSight Biologics) -- has sufficient net working capital to meet its obligations through Feb-26, then revenues should ensure the company's operational continuity through 2026

    • M&A

      • GLEN.LN (Glencore) -- and Rio Tinto reportedly restart merger talks -- FT

      • GLEN.LN (Glencore) -- confirms preliminary discussions with Rio Tinto regarding possible combination of some or all of their businesses

      • KEMIRA.FH (Kemira) -- acquires Ohio-based AquaBlue, Inc; deal is valued at under $10M

      • Carlyle expected to shortly start the sell-off of The Very Group - Sky News

    • Healthcare

      • ROG.SW (Roche Holding) -- MediLink Therapeutics (private) announces out-license agreement worth up to $570M (19:00ET)

      • ANAB (AnaptysBio) -- files motion to dismiss Tesaro's claim of anticipatory breach of contract

      • ALCLS.FP (Cellectis SA) -- issues 2026 strategy; first interim analysis of Phase 2 BALLI-01 trial expected to complete in Q4

      • FARN.LN (Faron Pharmaceuticals) -- discloses approval of share subscriptions based on special rights in connection with convertible bond arrangement

    • Other

      • TRMD.A.DC (TORM Plc) -- SEC filing: SCHEDULE 13D/A (Filed by Oaktree Capital Group Holdings GP, LLC)

      • MTX.GR (MTU Aero Engines) -- announces initial conversion price for new convertible bonds is €578.29

      • REP.SM (Repsol) -- seeking US license to restart exports of Venezuelan crude - Bloomberg

      • GTT.FP (Gaztransport & Technigaz) -- receives an order from Samsung Heavy Industries for the tank design of two new LNG Carriers

      • VRLA.FP (Verallia) -- announces that the Italian Competition Authority has decided to close without further action the investigation launched in 2023 concerning several glass manufacturers

      • SUNN.SW (Sunrise Communications) -- announces focus on simplified company structure and efficient processes

      • EC's Digital Networks Act will not be harsh on big tech - Reuters

      • L'Oreal, Kering among companies maintaining Triple A ranking in CDP's 2025 climate disclosure list (8-Jan)

      • Merger between Teck Resources and Anglo American likely to receive EU antitrust approval - Reuters

      • Trump administration and Congress reportedly plans this week to overturn Biden era mining ban in northern Minnesota - Reuters

  • Key rating changes

    • Upgrades

      • (NULL) -- Morgan Stanley upgrades AUTO.LN, G24.GR, SMG.SW; downgrades RMV.LN

      • ANTO.LN (Antofagasta) -- to buy from neutral at Goldman Sachs

      • BNP.FP (BNP Paribas) -- to overweight from neutral at JPMorgan

      • NSKOG.NO (Norske Skog) -- to buy from hold at Pareto

      • OR.FP (L'Oreal) -- to buy from neutral at UBS

    • Downgrades

      • CLNX.SM (Cellnex Telecom) -- to neutral from buy at Goldman Sachs

      • GLE.FP (Societe Generale)-- to reduce from buy at Kepler Cheuvreux

  • Data

    • Nikkei +1.57% to 51917.39

    • Hang Seng +0.26% to 26218.38

    • Shanghai Composite +0.71% to 4112.13

    • S&P futures (0.3) vs prior close of 6962.0

    • €-$ (0.0008) or (0.07%) to 1.1654

    • $-¥ +0.51 or +0.32% to 157.38

    • €-¥ +0.50 or +0.27% to 183.40

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE